PREVALENCE OF PULMONARY EMBOLISM IN PATIENTS SUFFERING FROM ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Main Article Content

Kaleemullah
Mujahid Hussain
Sobia Rehman
Mehreen Umair
Abdul Rehman Azam
Sohail Akhtar

Keywords

Chronic obstructive pulmonary disease, COPD exacerbation & pulmonary embolism.

Abstract

To determine the frequency of pulmonary embolism in patients presented with COPD exacerbations.


Methodology: This cross-sectional study was conducted in Indus Hospital, Karachi, Pakistan from July 2024 to December 2024. A total of 57 patients with COPD exacerbations were analyzed. COPD was defined as: if the ratio of FEVI/FVC was < 0.7 on post-bronchodilator spirometry, then it was considered a case of COPD. Demographic characteristics, vital signs, arterial blood gas, and chest x-ray details were noted. A complete blood count and pulmonary angiography were done to assess the presence of pulmonary embolism.


Results: A total of 57 patients with COPD exacerbation were included and analyzed. The mean age, BMI, and duration of COPD were 63.56±12.06 years, 23.45±23.45 kg/m2, and 17.72±10.31 years. There were 53(93.0%) male, and 4 (7.0%) females. There were 41 (71.9%) patients who belonged to rural areas. History of smoking was present in 55 (96.5%) patients. Seventeen (29.82%) patients were hypertensive, while 3 (5.26%) had diabetes mellitus. Frequency of PE in patient with COPD exacerbation was 8.8% (n=5/57). Relatively higher BMI was associated with the presence of PE (p=0.016).


Conclusion: The prevalence of pulmonary embolism was notable in patients with COPD exacerbations. Pulmonary embolism should be taken more seriously, especially when chest discomfort is present and no obvious infectious cause can be found.

Abstract 8 | PDF Downloads 6

References

1. Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, et al. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. Am J Respir Crit Care Med. 2022;206(11):1317-1325. doi: 10.1164/rccm.202204-0671PP
2. Choate R, Pasquale CB, Parada NA, Prieto-Centurion V, Mularski RA, Yawn BP. The Burden of Cough and Phlegm in People With COPD: A COPD Patient-Powered Research Network Study. Chronic Obstr Pulm Dis. 2020;7(1):49-59. doi: 10.15326/jcopdf.7.1.2019.0146
3. Czarnecka-Chrebelska KH, Mukherjee D, Maryanchik SV, Rudzinska-Radecka M. Biological and Genetic Mechanisms of COPD, Its Diagnosis, Treatment, and Relationship with Lung Cancer. Biomedicines. 2023;11(2):448. doi: 10.3390/biomedicines11020448
4. Sun YC. Chronic obstructive pulmonary disease in primary healthcare institutions in China: Challenges and solutions. Chronic Dis Transl Med. 2020;6(4):219-223. doi: 10.1016/j.cdtm.2020.05.007
5. Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Global Initiative for chronic obstructive lung disease: The changes made. Cureus. 2019;11(6):e4985. doi:10.7759/cureus.4985
6. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020. https://goldcopd.org/gold-reports/. Accessed 23 Jun 2020.
7. Shapira-Rootman M, Beckerman M, Soimu U, Nachtigal A, Zeina AR. The prevalence of pulmonary embolism among patients suffering from acute exacerbations of chronic obstructive pulmonary disease. Emerg Radiol. 2015;22(3):257-260. doi:10.1007/s10140-014-1280-7
8. Castellana G, Intiglietta P, Dragonieri S, Carratù P, Buonamico P, Peragine M, et al. Incidence of deep venous thrombosis in patients with both Pulmonary Embolism and COPD. Acta Biomed. 2021;92(3):e2021210. doi: 10.23750/abm.v92i3.11258
9. Pulmonary Embolism. Breathe (Sheff). 2019;15(4):360-365. doi: 10.1183/20734735.ELF154
10. Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013 Spring;18(2):129-38. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3718593/
11. Alamri AS, Alamri MS, Al-Qahatani F, Alamri AS, Alghuthaymi AM, Alamri AM, et al. Prevalence and Risk Factors of Deep Vein Thrombosis Among Adult Surgical Patients in Aseer Central Hospital, Saudi Arabia. Cureus. 2023;15(10):e47856. doi: 10.7759/cureus.47856
12. Aleva FE, Voets LWLM, Simons SO, de Mast Q, van der Ven AJAM, Heijdra YF. Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD. Chest. 2017;151(3):544-554. doi:10.1016/j.chest.2016.07.034
13. Fortis S, Comellas AP, Bhatt SP, Hoffman EA, Han MK, Bhakta NR, et al. Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function. Chest. 2021;160(1):94-103. doi: 10.1016/j.chest.2021.01.067
14. Albitar HAH, Iyer VN. Adherence to global initiative for chronic obstructive lung disease guidelines in the real world: Current understanding, barriers, and solutions. Curr Opin Pulm Med. 2020;26(2):149-154. doi:10.1097/MCP.0000000000000655
15. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334-1357. doi:10.1161/HYPERTENSIONAHA.120.15026
16. Lam WMJ, Al‐Khalifah R, Florez ID, Cruz‐Lopes L, Sekercioglu MF, Couban R, et al. Management of type 2 diabetes using non‐insulin glucose‐lowering therapies: A critical appraisal of clinical practice guidelines with the AGREE II instrument. Diabet Med. 2020;37(4): 636-647. doi:10.1111/dme.14231
17. Hassen MF, Tilouche N, Jaoued O, Elatrous S. Incidence and Impact of Pulmonary Embolism During Severe COPD Exacerbation. Respir Care. 2019; 64(12):1531-1536. doi:10.4187/respcare.06661
18. Furcada JM, Castro HM, De Vito EL, Grande Ratti MFG, Posadas-Martinez ML, Giunta DH, et al. Diagnosis of Pulmonary Embolism in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Cross-sectional Study. Clin Respir J. 2020. 14(12):1176-1181. doi:10.1111/crj.13257
19. Jindal A, Rathore YS, Joshi V, Jain S, Khippal N. A cross-sectional study for the evaluation of pulmonary embolism in unexplained dyspnea in acute exacerbation of chronic obstructive pulmonary disease. Ind J Resp Care. 2020;9(2):191–195. doi:10.4103/ijrc.ijrc_1_20
20. Dentali F, Pomero F, Di Micco P, La Regina M, Landini F, Mumoli N, et al. Prevalence and risk factors for pulmonary embolism in patients with suspected acute exacerbation of COPD: a multi-center study. Eur J Intern Med. 2020;80:54-59. doi:10.1016/j.ejim.2020.05.006
21. Jing X, Zhang G, Zhang B, Dai L, Wang X, Jia L, et al. Efficacy and safety of low-dose urokinase for the treatment of hemodynamically stable AECOPD patients with acute pulmonary thromboembolism. Clin Respir J. 2018;12(5):1882-1890. doi:10.1111/crj.12751
22. Aleva FE, Voets LWLM, Simons SO, de Mast Q, van der Ven AJAM, Heijdra YF. Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis. Chest. 2017;151(3):544-554. doi:10.1016/j.chest.2016.07.034
23. Schmid J, Nagy E, Kaufmann-Bühler AK, Steiner J, Janisch M, Janek E, et al. Diagnosing Pulmonary Embolism With Computed Tomography Pulmonary Angiography: Diagnostic Accuracy of a Reduced Scan Range. J Thorac Imaging. 2022;37(5):323-330. doi: 10.1097/RTI.0000000000000664
24. Fu X, Zhong Y, Xu W, Ju J, Yu M, Ge M, et al. The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review. PLoS One. 2021;16(9):e0256480. doi: 10.1371/journal.pone.0256480

Most read articles by the same author(s)